The overall aim of this proposal is to study the biochemical pharmacology of anti-human immunodeficiency virus type (HIV-1) compounds. The current compounds of interest will be anti-HIV nucleoside analogs with a special focus on 4'-ethynyl D4T (4'-Ed4T), which was discovered in this laboratory in collaboration with two Japanese groups. This compound has unique anti-HIV activity different from other anti-HIV nucleoside analogs. We propose to study the biochemical pharmacology of this newly discovered anti-HIV D-thymidine analog, 4'-Ed4T.The following specific aims are based on these original findings in my laboratory. 1. Metabolism of 4'-Ed4T in cells. a. Study the time dependent phosphorylation of 4'-Ed4T. b. Study the dose dependent formation of 4'-Ed4T nucleotides. c. Study the intracellular concentration of 4'-Ed4T nucleotide metabolites after drug removal. d. Study the cellular enzymes responsible for the phosphorylation of 4'-Ed4T in cells. 2. Interaction of 4'-Ed4T metabolites with HIV reverse transcriptase. 3. Impact of 4'-Ed4T host on DMA synthesis. 4. Characterization of HIV resistant to 4'-Ed4T. a. Engineering 4'-Ed4T resistant mutants and sensitivity of the defined mutation virus to 4'-Ed4T. b. To determine the replication capacity (RC) coefficient (calculations described below) of 4'-Ed4T resistant strains. c. To understand the impact of mutations P119S, T165A and M184V on HIV RT behavior. The studies proposed will provide not only the key preclinical information about the newly discovered 4'- Ed4T which will be under clinical development and the structure activity relationship of the biochemical determinants studied, but also the role of potential biochemical determinants for the action of thymidine analogs including AZT and D4T. 4'-Ed4T could have the potential to replace AZT or D4T in anti-HIV HARRT and in overcoming drug resistant virus to other anti-HIV drugs at the relevant dosage without causing toxicity. ? ? ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI038204-13
Application #
7233265
Study Section
AIDS Discovery and Development of Therapeutics Study Section (ADDT)
Program Officer
Turk, Steven R
Project Start
1995-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
13
Fiscal Year
2007
Total Cost
$320,430
Indirect Cost
Name
Yale University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Wang, Ying; Chen, Shao-Ru; Yang, Xiaoming et al. (2018) Structure-activity relationships of cryptopleurine analogs with E-ring modifications as anti-hepatitis C virus agents. Bioorg Med Chem 26:630-636
Wang, Ying; Lam, Wing; Chen, Shao-Ru et al. (2016) Tylophorine Analog DCB-3503 Inhibited Cyclin D1 Translation through Allosteric Regulation of Heat Shock Cognate Protein 70. Sci Rep 6:32832
Tsao, Ning; Lee, Ming-Hsiang; Zhang, Wei et al. (2015) The contribution of CMP kinase to the efficiency of DNA repair. Cell Cycle 14:354-63
Wu, Chien-Huang; Wang, Chuan-Jen; Chang, Chun-Ping et al. (2015) Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors. J Med Chem 58:1452-65
Fan, Jiyun; Wang, Ying; Xiong, Hui et al. (2014) Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibility. J Gen Virol 95:2523-30
Selvaraj, S; Ghebremichael, M; Li, M et al. (2014) Antiretroviral therapy-induced mitochondrial toxicity: potential mechanisms beyond polymerase-? inhibition. Clin Pharmacol Ther 96:110-20
Haraguchi, Kazuhiro; Takeda, Shingo; Kubota, Yutaka et al. (2013) From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir. Curr Pharm Des 19:1880-97
Tsou, Lun K; Cheng, Yao; Cheng, Yung-Chi (2012) Therapeutic development in targeting protein-protein interactions with synthetic topological mimetics. Curr Opin Pharmacol 12:403-7
Tsou, Lun K; Chen, Chin-Ho; Dutschman, Ginger E et al. (2012) Blocking HIV-1 entry by a gp120 surface binding inhibitor. Bioorg Med Chem Lett 22:3358-61
Haraguchi, Kazuhiro; Shimada, Hisashi; Kimura, Keiogo et al. (2011) Synthesis of 4'-Ethynyl-2'-deoxy-4'-thioribonucleosides and Discovery of a Highly Potent and Less Toxic NRTI. ACS Med Chem Lett 2:692-697

Showing the most recent 10 out of 32 publications